Form 4: RenovoRx Chief Medical Officer Gifts 400,000 Shares to Family Trusts

Ramtin Agah, Chief Medical Officer and Director of RenovoRx, Inc., reported a gift of 400,000 shares of common stock to trusts for his children, reducing his direct beneficial ownership.

Summary

• Ramtin Agah, the Chief Medical Officer and a Director of RenovoRx, Inc. (RNXT), reported a transaction on April 22, 2025.
• The transaction involved a bona fide gift of 400,000 shares of the Issuer's common stock.
• The shares were gifted to trusts established for the benefit of Mr. Agah's children.
• Following this transaction, Mr. Agah's direct beneficial ownership in RenovoRx, Inc. common stock stands at 713,460 shares.
• Mr. Agah is not a trustee or beneficiary of these trusts and therefore no longer holds a beneficial ownership interest in the gifted shares.

Sentiment

Score: 5

Explanation: The document reports a routine insider gift transaction, which is generally considered neutral. It is not a sale for cash, nor does it provide operational or financial performance updates.

Future Outlook

This SEC Form 4 filing reports an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Management Comments

• "On April 22, 2025, the reporting person made a bona fide gift of an aggregate of 400,000 shares of the Issuer's common stock to trusts for the benefit of the reporting person's children. The reporting person is not a trustee or beneficiary of such trusts and therefore no longer has a beneficial ownership interest in the subject shares."

Industry Context

This filing is a routine insider transaction disclosure and does not provide information relevant to broader industry trends or competitive landscape analysis for the biotechnology or medical device sector.

Related Party Transactions

• Ramtin Agah, the Chief Medical Officer and Director, gifted 400,000 shares of common stock to trusts for the benefit of his children. While a personal transaction, it involves related parties (family members).

Stakeholder Impact

• Shareholders: The transaction represents a reduction in direct beneficial ownership by a key insider, though it is a gift rather than a sale, which typically carries a different market interpretation. The overall impact on the company's operations or strategic direction is negligible.

Key Dates

Keywords

RenovoRx, RNXT, Ramtin Agah, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, Chief Medical Officer, Director